NCT05608135

Brief Summary

At present, diagnosis and recognition of depression and bipolar disorder are mainly based on subjective evidence such as clinical interview and scale evaluation. The corresponding diagnosis basis has some shortcomings, such as poor diagnostic reliability and failure in early identification of bipolar disorder. Therefore, it is of great significance to explore objective diagnostic indicators to remedy the deficiencies. Therefore,the investigators collect psychological and physiological information data of patients with bipolar disorder and depression.Then the investigators aim to construct and verify the multidimensional emotion recognition model to analyze the personality characteristics, negative emotions and cognitive reactions of different individuals, and form a systematic accurate recognition and evaluation tool.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
960

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

March 10, 2023

Status Verified

March 1, 2023

Enrollment Period

2 years

First QC Date

September 28, 2022

Last Update Submit

March 9, 2023

Conditions

Keywords

Bipolar Disorder DepressionMajor DepressionMachine LearningSkin PotentialMicro-Facial ExpressionElectroencephalogram

Outcome Measures

Primary Outcomes (3)

  • facial action unit detection

    The research recruits subjects to look at pictures and videos and then use cameras to record facial microexpressions. Finally, the research uses machine learning methods to analyze facial micro-expressions. Facial micro-expressions (MEs) are involuntary movements of the face that occur spontaneously when a person experiences an emotion but attempts to suppress or repress the facial expression, typically found in a high-stakes environment.

    Baseline

  • event-related potentials

    An electroencephalogram (EEG) is a test that measures electrical activity in the brain using small, metal discs (electrodes) attached to the scalp. Brain cells communicate via electrical impulses and are active all the time, even during asleep. This activity shows up as wavy lines on an EEG recording. The research recruits subjects to look at videos and pictures and use electroencephalography to record event-related potentials. Finally, we use time domain analysis and frequency analysis to get the results

    Baseline

  • Galvanic skin response

    The skin also has electrical activity, which is in constant, slight variation, and can be measured and charted. The skin's electrical conductivity fluctuates based on certain bodily conditions, and this fluctuation is called the galvanic skin response.We recruited subjects to watch videos and pictures and record galvanic skin response. Finally, we use time domain analysis and frequency analysis to get the results

    Baseline

Eligibility Criteria

Age15 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The study will be conducted primarily at the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China, starting from October 1, 2021, with an estimated total enrollment of 120 participants. Other participating centers include Peking University Sixth Hospital, At the Third Affiliated Hospital of Sun Yat-sen University, At the Second Affiliated Hospital of Kunming Medical University, At Wuhan People's Hospital, At Xiaoshan Hospital in Zhejiang Province, At Wenzhou seventh People's Hospital, At Ruian Fifth People's Hospital, respectively an evaluated 120 participants to be recruited.All research centers of the participants are from China. In screening interviews, the above criteria were carefully examined by two independent investigators.

You may qualify if:

  • Age 15-55, regardless of gender;
  • The brief International Neuropsychiatric Interview Chinese version (MINI) was used to meet the diagnostic criteria for DSM-IV-TR depressive disorder or bipolar disorder (type I);
  • Total score of Hamilton Depression Scale (HAMD-17) ≥17, and Young's Manic Scale (YMRS) ≤6;
  • Junior high school or above.

You may not qualify if:

  • The patient conforms to DSM-IV schizophrenia and related spectrum disorders.
  • The patient has a history of severe head trauma (loss of consciousness for more than 5 minutes), current or previous history of epilepsy, intracranial hypertension, or other serious neurological diseases;
  • Had a history of alcohol or psychoactive substance abuse/dependence in the 6 months prior to the test;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Zhejiang University

Hangzhou, Zhejiang, 310000, China

RECRUITING

MeSH Terms

Conditions

Bipolar DisorderDepressive Disorder, Major

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental DisordersDepressive Disorder

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department of Psychaitry , First Affiliated Hospital of Zhejiang University Affiliation: First Affiliated Hospital of Zhejiang University

Study Record Dates

First Submitted

September 28, 2022

First Posted

November 8, 2022

Study Start

December 1, 2022

Primary Completion

December 1, 2024

Study Completion

December 1, 2025

Last Updated

March 10, 2023

Record last verified: 2023-03

Locations